Navigation Links
Cadence Pharmaceuticals Recognized As A Top Workplace In San Diego Based On Employee Feedback
Date:11/8/2013

SAN DIEGO, Nov. 8, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today it has been recognized as one of U-T San Diego's Top Workplaces. The Top Workplaces are determined exclusively based on employee feedback provided through an anonymous survey.

"We are extremely honored that our employees' feedback has resulted in this recognition," said Ted Schroeder, President, CEO, and co-founder of Cadence Pharmaceuticals. "Building and sustaining a great working environment and a strong culture has been a top priority since we founded the company in 2004. The leadership team is focused on driving competitive advantage by consistently fostering a strong set of core values and maintaining our dynamic company culture."

The survey, which was conducted by leading research firm on organizational health and employee engagement, WorkplaceDynamics, LLP, included questions around company direction, execution, connection to the company, management, pay and benefits, and employee engagement. Cadence Pharmaceuticals had an exceptional 92 percent employee response rate on the survey.

"The key to Cadence Pharmaceuticals' employee satisfaction is a culture that encourages employee feedback," said Diane Sheehan, Vice President of Human Resources at Cadence Pharmaceuticals. "Each employee is important to our success, so it is imperative that we gather, consider and take action on their input. We believe that this approach will help as we strive to achieve our corporate objectives and provide value to the hospital community and our business partners."

The following anonymous testimonials were excerpted from the survey:

  • "I truly believe in the product I promote and believe I work with the best people in the industry. Management is transparent and supportive all the way up the chain of command. I have never been more satisfied with work."
  • "I am empowered to make decisions and contribute. Our CEO is accessible and easy to approach. [Cadence Pharmaceuticals has a] strong unique culture in which we can all contribute and be a part of the company's success."

In addition, Cadence Pharmaceuticals was recognized as a recipient of a 2013 Workplace Excellence Award presented by the San Diego Society for Human Resource Management's (SD SHRM). This award, which is based on the assessment of an expert judging panel assembled by SD SHRM, recognizes Cadence Pharmaceuticals' proactive efforts to involve its employees in the ongoing strengthening of the company and its culture. This is the second time Cadence Pharmaceuticals has won a SD SHRM Workplace Excellence Award, with the first award in 2010.

Both awards were presented at a ceremony sponsored by U-T San Diego, held at the Hilton La Jolla Torrey Pines on November 7, 2013.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals' corporate overview may be viewed on the Investors page of www.cadencepharm.com under "Events & Presentations" by selecting "Corporate Overview."

Cadence® is a trademark of Cadence Pharmaceuticals, Inc.

Investor Contact:
William R. LaRue   
SVP & Chief Financial Officer    
Cadence Pharmaceuticals, Inc.       
Phone: 858-436-1400                                                                                     

Media Contact:
Cuyler Mayer     
Edelman
Phone: 323-202-1073


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cadence Pharmaceuticals Reports Third Quarter 2013 Financial Results
2. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Third Quarter 2013 Financial Results On November 5, 2013
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present At The Stifel Nicolaus Healthcare Conference 2013 On September 11, 2013
4. Cadence Pharmaceuticals Comments on USPTOs Non-Final, Initial Office Action on Reexamination of Patent
5. Cadence Pharmaceuticals Appoints Laureen DeBuono to its Board of Directors
6. Cadence Pharmaceuticals To Present At The 2013 Wedbush PacGrow Life Sciences Management Access Conference On August 13, 2013
7. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
8. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss Second Quarter 2013 Financial Results On July 31, 2013
9. Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
10. Cadence Pharmaceuticals To Host Conference Call And Webcast To Discuss First Quarter 2013 Financial Results On May 2, 2013
11. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... HOUSTON , 8. Februar 2016 /PRNewswire/ ... veröffentlichte heute eine Infografik mit dem Titel ... ganzen Welt), mit der der Krankheit gegenüber ... die dazu ermutigen soll, Medikamentenresistenz bei Epilepsie ... der allgemeinen Diskussion zu machen. Mithilfe der ...
(Date:2/5/2016)... Feb. 5, 2016  ivWatch, a medical devices company, is ... Award granted by Governor Terry McAuliffe,s office. ivWatch ... February 25th at an event to be held at the ... award honors professionals and business that have made significant contributions ... Logo - http://photos.prnewswire.com/prnh/20160205/330117LOGO ...
(Date:2/5/2016)... -- Aethlon Medical, Inc. (Nasdaq: AEMD ), today announced ... presenting at Source Capital Group,s 2016 Disruptive Growth & Healthcare ... 2:15 p.m. ET on Wednesday, February 10, 2016.  Mr. Joyce ... at 3:15 p.m. ET. http://www.aethlonmedical.com .  The webcast ... conclusion of the live event. The panel discussion will not ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with ... time to make a change in public health,” states Carole Baggerly, Director of ...
(Date:2/8/2016)... Las Vegas, NV (PRWEB) , ... February 08, 2016 , ... ... transformation on February 9th, 10th and 11th, 2016 in honor of his birthday on ... relationships and true happiness. Mahendra Trivedi is known by over 250,000 people from ...
(Date:2/7/2016)... (PRWEB) , ... February 07, 2016 , ... Women's Excellence ... National Wear Red Day. National Wear Red Day is the first Friday each ... Heart disease and stroke cause 1 in 3 deaths among women each year – ...
(Date:2/6/2016)... ... February 06, 2016 , ... US Sports Camps is proud ... . This event brings together top non-profit leaders, ultimate organizations, and coaches from around ... Valerio Iani, Bay Area Disc Program Director of Youth and Education, describes this year ...
(Date:2/5/2016)... ... 2016 , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ran the Miami ... in 2003. This year, he ran all 26.2 miles with a green 25-pound ShelterBox ... Miami Heat. , This Sunday, while many are watching the Superbowl, Steven Tonkinson will ...
Breaking Medicine News(10 mins):